Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bioavailability estimation by semisimultaneous drug administration: a Monte Carlo simulation study.

M O Karlsson1, U Bredberg

  • 1Department of Biopharmaceutics and Pharmacokinetics, Faculty of Pharmacy, University of Uppsala, Sweden.

Journal of Pharmacokinetics and Biopharmaceutics
|April 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Population pharmacokinetics of colistin and the relation to survival in critically ill patients infected with colistin susceptible and carbapenem-resistant bacteria.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2020
Same author

Handling underlying discrete variables with bivariate mixed hidden Markov models in NONMEM.

Journal of pharmacokinetics and pharmacodynamics·2019
Same author

CORRIGENDUM: Implementing Pharmacogenomics in Europe: Design and Implementation Strategy of the Ubiquitous Pharmacogenomics Consortium.

Clinical pharmacology and therapeutics·2018
Same author

Reduced and optimized trial designs for drugs described by a target mediated drug disposition model.

Journal of pharmacokinetics and pharmacodynamics·2018
Same author

Pharmacometric Analysis of the Relationship Between Absolute Lymphocyte Count and Expanded Disability Status Scale and Relapse Rate, Efficacy End Points, in Multiple Sclerosis Trials.

Journal of clinical pharmacology·2018
Same author

Model averaging for robust assessment of QT prolongation by concentration-response analysis.

Statistics in medicine·2017

This study demonstrates a novel method for determining drug absorption characteristics using Monte Carlo simulations. Optimal experimental design allows accurate bioavailability assessment within 12 hours, even with simplified models.

Area of Science:

  • Pharmacokinetics
  • Drug Absorption
  • Bioavailability Studies

Background:

  • Accurate determination of drug absorption is crucial for bioavailability studies.
  • Traditional methods may require extensive sampling durations.
  • Novel simulation-based approaches can optimize experimental design.

Purpose of the Study:

  • To evaluate a novel method for determining drug absorption characteristics using Monte Carlo simulations.
  • To identify factors influencing parameter estimation in bioavailability studies.
  • To assess the method's utility in evaluating relative bioavailability of extravascular doses.

Main Methods:

  • Monte Carlo simulations were employed to model drug absorption and disposition.
  • Kinetic rate constants (ka, lambda 1, lambda 2) were varied to mimic different drug properties.

Related Experiment Videos

  • Experimental design parameters including dose interval, ratio, order, and sampling duration were simulated.
  • Model fitting was performed using various disposition and absorption models.

    • Main Results:

    • Drug absorption characteristics were adequately determined within 12 hours with appropriate experimental design.
    • Fitting simpler or more complex disposition models yielded comparable accuracy and precision to the true model.
    • The proposed method accurately estimated relative rate and extent of absorption for extravascular doses with rapid to moderate absorption rates.
    • Use of improper absorption models led to reduced accuracy but indicated poor fits.

    Conclusions:

    • The novel simulation-based method enables efficient and accurate determination of drug absorption characteristics.
    • Optimal experimental design is key to achieving reliable bioavailability estimates within shorter durations.
    • The method is effective for assessing relative bioavailability of extravascular drug formulations.